Acorda Therapeutics, Inc. (NASDAQ: ACOR ) today announced that its Board of Directors has elected John Kelley to serve as non-executive board Chair, effective November 25, 2019. Mr. Kelley has been a board member at Acorda since 2008. “I am delighted that John will be chairing Aco...

Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that Jane Wasman, President, International & General Counsel, is resigning from the company effective at the end of this year. Ms. Wasman plans to expand her role as a member of corporate boards, and to provide consulting services...

Acorda Therapeutics ( ACOR +21% ) is up on triple normal volume in response to its Q3 results released after the close yesterday. More news on: Acorda Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...